Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Quality Improvement Opportunity for VFC Providers The Immunization Quality Improvement for Providers (IQIP) Program is a CDC initiative to help providers implement strategies that support their immunization activities. VFC-enrolled practices are chosen by the CDC for IQIP enrollment each year. However, starting this project year (July 1, 2023 to...

Vaccine Shipment Delays During the December Holiday Submit orders by Friday, December 8! During the holiday season – from mid-December to early January – the distribution center that ships vaccine provided through the Vaccines for Children (VFC), Vaccines for Adults at Risk (VFAAR), and Bridge Access programs...

Deauthorized COVID-19 Products As a reminder, only the approved 2023 - 2024 COVID-19 products listed below may be administered at this time: Authorized 2023 - 2024 ProductsFormulation: Monovalent XBB.1.5 Pfizer 12+: NDC 00069-2362-10 Pfizer 5-11: NDC 59267-4331-02 Pfizer 6mo-4yrs: NDC 59267-4315-02 Moderna 12+: NDC 8077-0102-95 Moderna 6mo-11yrs: NDC 8077-0287-92 Novavax 12+: NDC 80631-0105-02 Previously...

Mpox Vaccine Deliveries Paused for Thanksgiving Mpox vaccine deliveries will be paused during the week of Thanksgiving, November 20-24, 2023. Ordering will remain open this week until Wednesday, November 15 by 5:00 PM. The last delivery for mpox vaccine will be on Thursday, November 16.  Remember to submit...

Nirsevimab (Beyfortus) Updates Due to the unprecedented demand for nirsevimab, supply of this product is extremely limited through both the Vaccines for Children (VFC) program and the private market. Below is an update on available supply and tips on how to prioritize use of available doses....

Pneumococcal Vaccination for Asthmatic Pediatric Patients  This blog post is part of a series highlighting important changes in the 2024 ACIP immunization schedules. This series is written alongside newly onboarded Immunization Program Medical Specialist, Dr. Mayssa Abuali. Dr. Abuali is board certified in general pediatrics, pediatric infectious...

Dosing of Moderna COVID-19 Vaccine (2023-2024 Formula) FDA released important information to ensure correct administration of the Moderna COVID-19 vaccine (2023-2024 formula) for individuals 6 months through 11 years.   The announcement states that providers who administer Moderna COVID-19 vaccine (2023-2024 formula) to individuals ages 6 months through 11...

Supply Updates and Borrowing VFC Doses The nirsevimab supply shortage continues to evolve and is not expected to resolve soon. Review this CDC advisory with updates about nirsevimab supply and recommendations to prioritize the use of the limited supply of this product. With these limitations, the Immunization Program wants...

Nirsevimab (Beyfortus) and COVID-19 Updates Nirsevimab Due to high demand and limited supply cited by the CDC, nirsevimab (Beyfortus) ordering through VFC has been put on hold as of October 17, 2023. The CDC is working with Sanofi to secure a supply of this immunization within the...

2023-2024 Novavax Now Available to Order Novavax COVID-19 vaccine, adjuvanted (2023-2024 formula) is now available to order. 2023-2024Novavax is authorized for individuals 12 years and older.  This product package contains two multi dose vials each containing five doses. The NDC for this product is NDC # 80631-0105-02.  It can...